Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial

Title
Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial
Authors
Keywords
-
Journal
HAEMATOLOGICA
Volume 101, Issue 5, Pages e192-e195
Publisher
Ferrata Storti Foundation (Haematologica)
Online
2016-01-28
DOI
10.3324/haematol.2015.135418

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now